Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas
In this patient cohort, there was no local control benefit for larger GTV-to-PTV expansions. For patients with tumors not eligible for SRS, fractionated stereotactic treatment workflow with ≤3 mm PTV expansions is an effective approach for WHO grade 1 meningiomas.
Authors
- Dennis C. Shrieve (ORCID: https://orcid.org/0000-0002-9212-7249)
- Donald M. Cannon (ORCID: https://orcid.org/0000-0001-7512-3767)
- Felicia H. Lew (ORCID: https://orcid.org/0000-0002-2674-7319)
- Calvin B. Rock (ORCID: https://orcid.org/0000-0002-1839-5720)
- Vikren Sarkar (ORCID: https://orcid.org/0000-0003-4010-8035)
- Christian B. Rock
- Christopher R. Weil (ORCID: https://orcid.org/0000-0002-8262-6626)
- Cristina DeCesaris (ORCID: https://orcid.org/0000-0003-4970-3578)
- Randy L. Jensen (ORCID: https://orcid.org/0000-0002-2824-4221)
- Lindsay Burt (ORCID: https://orcid.org/0000-0002-2040-2416)
- Nicholas Gravbrot (ORCID: https://orcid.org/0000-0003-2024-6481)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Washington (US)
- University of Utah (US)
- Huntsman Cancer Institute (US)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1097/coc.0000000000001193
- Citations
- 1
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 1.35